Zeng Lab
Home
About
Professor Zeng Qi
Lab Members
Research
Publications
News
Contact
Gallery
More
27 May 2025
Phase II Trial Completed – Singapore’s New Anti-Cancer Drug One Step Away from Market
完成二期试验 本地抗癌新药离面市仅一步 (After Completing The Phase II Clinical Trial, The Local New Anti-Cancer Drug Is Only One Step Away From Being Launched On The Market)
09 May 2025
SINGAPORE-DEVELOPED CANCER IMMUNOTHERAPY OFFERS NEW HOPE FOR LATE-STAGE CANCER PATIENTS PRL3-zumab demonstrates safety and clinical benefit in FDA-approved Phase II trial across multiple cancer types
